{"gene":"DTX1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2018,"finding":"DTX1 colocalizes with Notch1 on tubulovesicular recycling endosomes and controls Notch1 endosomal sorting; DTX1 silencing leads to enhanced Notch1 recycling via a rab4a-mediated route, increasing Notch1 cell-surface levels and signaling. DTX1 also ubiquitinates PI5P4Kγ (a lipid kinase for PI(4,5)P2 production) on recycling endosomes, and loss of PI5P4Kγ activity decreases Notch1 recycling, supporting a model where DTX1 controls Notch1 transport by targeting PI5P4Kγ.","method":"siRNA silencing, immunolocalization, activity-based ubiquitination substrate screen, Rab4a transport assays, pharmacological inactivation of PI5P4Kγ","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (localization, loss-of-function, substrate screen, epistasis with rab4a and PI5P4Kγ) in a single focused mechanistic study","pmids":["29440432"],"is_preprint":false},{"year":2024,"finding":"DTX1 interacts with NLRP3 and promotes its ubiquitination and proteasomal degradation, thereby suppressing hepatocyte pyroptosis and inflammation. HNF4α transcriptionally activates DTX1 by binding its promoter.","method":"Co-immunoprecipitation, ubiquitination assay, luciferase reporter assay, chromatin immunoprecipitation, Western blotting, flow cytometry","journal":"Toxicology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and ubiquitination assay with ChIP for transcriptional regulation, single lab with multiple orthogonal methods","pmids":["39319341"],"is_preprint":false},{"year":2026,"finding":"DTX1 directly interacts with TUBB3 and promotes its ubiquitination and degradation in Kupffer cells, thereby blocking AKT signaling and suppressing M2 polarization of tumor-associated macrophages in hepatocellular carcinoma.","method":"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function experiments, in vivo xenograft/HCC models","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay and in vivo validation, single lab","pmids":["41577987"],"is_preprint":false},{"year":2026,"finding":"DTX1 directly interacts with ITGA5 and promotes its ubiquitination at lysine 137, leading to proteasome-dependent degradation; DTX1 overexpression maintains the contractile phenotype of vascular smooth muscle cells and attenuates aortic dissection progression in vivo.","method":"Co-immunoprecipitation, protein stability analysis, gain/loss-of-function in HASMCs and HEK-293T cells, BAPN-induced AD mouse model, Western blotting, immunofluorescence","journal":"Cardiovascular drugs and therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination site mapping (K137), in vivo model, single lab with multiple orthogonal methods","pmids":["42090073"],"is_preprint":false},{"year":2025,"finding":"DTX1 promotes microglial M1 polarization and neuroinflammation following traumatic brain injury; DTX1 overexpression increases proinflammatory cytokines and iNOS (M1 markers) and reduces Arg1 (M2 marker) via the NF-κB/IRF5 pathway, while DTX1 knockdown shifts microglia toward the M2 anti-inflammatory phenotype.","method":"Adenoviral overexpression and siRNA knockdown in vitro and in vivo (rat TBI model), gain/loss-of-function, cytokine measurement, marker expression analysis","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — both gain- and loss-of-function with in vivo validation, single lab, pathway placement via NF-κB/IRF5","pmids":["40660011"],"is_preprint":false},{"year":2000,"finding":"The human DTX1 gene encodes a cytoplasmic protein that functions as a positive regulator of the Notch signaling pathway; the gene maps to chromosomal region 12q24 and is composed of nine exons.","method":"Genomic characterization, chromosomal mapping, cDNA analysis","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genomic/positional characterization only, functional annotation inferred from prior literature without direct mechanistic experiment described in this paper","pmids":["11153911"],"is_preprint":false}],"current_model":"DTX1 is an E3 ubiquitin ligase that controls Notch1 endosomal sorting by ubiquitinating PI5P4Kγ on recycling endosomes to regulate PI(4,5)P2 production and receptor recycling, and additionally ubiquitinates substrates including NLRP3 (promoting its degradation to suppress inflammasome-driven pyroptosis), TUBB3 (inhibiting AKT-mediated M2 macrophage polarization), and ITGA5 (maintaining vascular smooth muscle cell contractile phenotype), while also modulating microglial M1 polarization through NF-κB/IRF5 signaling."},"narrative":{"mechanistic_narrative":"DTX1 is a cytoplasmic E3 ubiquitin ligase that regulates Notch signaling and shapes cellular phenotype by directing substrate ubiquitination and degradation [PMID:29440432, PMID:11153911]. On tubulovesicular recycling endosomes, DTX1 colocalizes with Notch1 and controls its endosomal sorting by ubiquitinating the lipid kinase PI5P4Kγ; loss of DTX1 enhances Rab4a-mediated Notch1 recycling and raises cell-surface Notch1 and signaling, while loss of PI5P4Kγ activity reduces Notch1 recycling, placing DTX1 upstream of receptor transport via control of PI(4,5)P2 production [PMID:29440432]. Beyond Notch trafficking, DTX1 acts on a series of substrates whose degradation reprograms inflammatory and structural cell states: it ubiquitinates NLRP3 to promote its proteasomal degradation and suppress hepatocyte pyroptosis, with DTX1 itself transcriptionally activated by HNF4α [PMID:39319341]; it degrades TUBB3 in Kupffer cells to block AKT signaling and suppress M2 polarization of tumor-associated macrophages [PMID:41577987]; and it ubiquitinates ITGA5 at lysine 137 to maintain the contractile phenotype of vascular smooth muscle cells and attenuate aortic dissection [PMID:42090073]. DTX1 also drives microglial M1 polarization and neuroinflammation through NF-κB/IRF5 signaling following traumatic brain injury [PMID:40660011].","teleology":[{"year":2000,"claim":"Established the molecular identity of human DTX1 as a cytoplasmic protein positioned as a positive regulator of Notch signaling, providing the gene model on which later mechanistic work was built.","evidence":"genomic characterization, chromosomal mapping (12q24), and cDNA analysis","pmids":["11153911"],"confidence":"Low","gaps":["Functional annotation inferred from prior literature without direct mechanistic experiment in this study","No biochemical demonstration of E3 ligase activity","No substrate identified"]},{"year":2018,"claim":"Resolved how DTX1 controls Notch1 signaling at the level of receptor trafficking, showing it restrains Notch1 recycling by ubiquitinating a lipid kinase on recycling endosomes rather than acting solely on the receptor.","evidence":"siRNA silencing, immunolocalization, ubiquitination substrate screen, Rab4a transport assays, and pharmacological inactivation of PI5P4Kγ","pmids":["29440432"],"confidence":"High","gaps":["Whether DTX1 directly ubiquitinates Notch1 in addition to PI5P4Kγ not resolved here","Ubiquitination site(s) on PI5P4Kγ not mapped","Regulation of DTX1 recruitment to recycling endosomes unknown"]},{"year":2024,"claim":"Extended DTX1 substrate repertoire to NLRP3, defining a degradative anti-inflammatory axis and placing DTX1 expression under HNF4α transcriptional control.","evidence":"reciprocal Co-IP, ubiquitination assay, luciferase reporter, and ChIP in a hepatocyte pyroptosis context","pmids":["39319341"],"confidence":"Medium","gaps":["Ubiquitin chain type and degradation route not characterized","Single-lab study without independent replication","Direct vs indirect ubiquitination of NLRP3 not fully dissected"]},{"year":2025,"claim":"Implicated DTX1 in driving proinflammatory microglial M1 polarization via NF-κB/IRF5 signaling after traumatic brain injury, linking it to neuroinflammatory phenotype switching.","evidence":"adenoviral overexpression and siRNA knockdown with cytokine/marker analysis in vitro and in a rat TBI model","pmids":["40660011"],"confidence":"Medium","gaps":["Ubiquitination substrate underlying the NF-κB/IRF5 effect not identified","Direction opposite to the anti-inflammatory NLRP3 axis not mechanistically reconciled","Single-lab study"]},{"year":2026,"claim":"Defined two further degradative substrate relationships—TUBB3 in Kupffer cells (suppressing AKT-driven macrophage M2 polarization) and ITGA5 at K137 in vascular smooth muscle cells (maintaining contractile phenotype)—broadening DTX1's role in tissue-specific phenotype control.","evidence":"Co-IP, ubiquitination assays with site mapping, gain/loss-of-function, and in vivo HCC and BAPN-induced aortic dissection models","pmids":["41577987","42090073"],"confidence":"Medium","gaps":["Ubiquitin chain linkage types not defined for TUBB3","Whether substrate selectivity is governed by tissue-specific cofactors unknown","Single-lab studies for each substrate"]},{"year":null,"claim":"How DTX1 selects among its diverse substrates (PI5P4Kγ, NLRP3, TUBB3, ITGA5) across cell types, and how its opposing pro- and anti-inflammatory outputs are reconciled, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model for substrate recognition or adaptor requirement","Structural basis of substrate engagement uncharacterized","Cell-type determinants of opposing inflammatory effects unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,3]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,2,3]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,3]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0]}],"complexes":[],"partners":["NOTCH1","PIP4K2C","NLRP3","TUBB3","ITGA5","HNF4A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86Y01","full_name":"E3 ubiquitin-protein ligase DTX1","aliases":["Protein deltex-1","Deltex1","hDTX1","RING-type E3 ubiquitin transferase DTX1"],"length_aa":620,"mass_kda":67.4,"function":"Functions as a ubiquitin ligase protein in vivo, mediating ubiquitination and promoting degradation of MEKK1, suggesting that it may regulate the Notch pathway via some ubiquitin ligase activity (By similarity). Regulator of Notch signaling, a signaling pathway involved in cell-cell communications that regulates a broad spectrum of cell-fate determinations. Mainly acts as a positive regulator of Notch, but it also acts as a negative regulator, depending on the developmental and cell context. Mediates the antineural activity of Notch, possibly by inhibiting the transcriptional activation mediated by MATCH1. Involved in neurogenesis, lymphogenesis and myogenesis, and may also be involved in MZB (Marginal zone B) cell differentiation. Promotes B-cell development at the expense of T-cell development, suggesting that it can antagonize NOTCH1","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q86Y01/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTX1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTX1","total_profiled":1310},"omim":[{"mim_id":"616110","title":"DELTEX E3 UBIQUITIN LIGASE 4; DTX4","url":"https://www.omim.org/entry/616110"},{"mim_id":"613143","title":"DELTEX E3 UBIQUITIN LIGASE 3L; DTX3L","url":"https://www.omim.org/entry/613143"},{"mim_id":"613141","title":"DELTEX E3 UBIQUITIN LIGASE 2; DTX2","url":"https://www.omim.org/entry/613141"},{"mim_id":"612659","title":"REGULATORY FACTOR X, 6; RFX6","url":"https://www.omim.org/entry/612659"},{"mim_id":"607299","title":"DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR; DNER","url":"https://www.omim.org/entry/607299"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":8.9},{"tissue":"lymphoid tissue","ntpm":11.7}],"url":"https://www.proteinatlas.org/search/DTX1"},"hgnc":{"alias_symbol":["hDx-1","RNF140"],"prev_symbol":[]},"alphafold":{"accession":"Q86Y01","domains":[{"cath_id":"3.30.720.50","chopping":"22-180","consensus_level":"medium","plddt":90.9036,"start":22,"end":180},{"cath_id":"3.30.40.10","chopping":"391-471","consensus_level":"high","plddt":87.556,"start":391,"end":471},{"cath_id":"3.30.390.130","chopping":"479-617","consensus_level":"high","plddt":93.2063,"start":479,"end":617}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86Y01","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86Y01-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86Y01-F1-predicted_aligned_error_v6.png","plddt_mean":74.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTX1","jax_strain_url":"https://www.jax.org/strain/search?query=DTX1"},"sequence":{"accession":"Q86Y01","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86Y01.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86Y01/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86Y01"}},"corpus_meta":[{"pmid":"29440432","id":"PMC_29440432","title":"PI5P4Kγ functions in DTX1-mediated Notch signaling.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29440432","citation_count":32,"is_preprint":false},{"pmid":"28366404","id":"PMC_28366404","title":"Sulfated diesters of okadaic acid and DTX-1: Self-protective precursors of diarrhetic shellfish poisoning (DSP) toxins.","date":"2017","source":"Harmful algae","url":"https://pubmed.ncbi.nlm.nih.gov/28366404","citation_count":23,"is_preprint":false},{"pmid":"25826053","id":"PMC_25826053","title":"Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX.","date":"2015","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/25826053","citation_count":22,"is_preprint":false},{"pmid":"28146432","id":"PMC_28146432","title":"Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28146432","citation_count":15,"is_preprint":false},{"pmid":"10398517","id":"PMC_10398517","title":"Evaluation of the use of two human cell lines for okadaic acid and DTX-1 determination by cytotoxicity assays and damage characterization.","date":"1998","source":"Natural toxins","url":"https://pubmed.ncbi.nlm.nih.gov/10398517","citation_count":13,"is_preprint":false},{"pmid":"26662803","id":"PMC_26662803","title":"Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26662803","citation_count":9,"is_preprint":false},{"pmid":"36374959","id":"PMC_36374959","title":"miR-210-3p Impairs Pancreatic β-Cell Function by Targeting Dtx1 in Gestational Diabetes Mellitus.","date":"2022","source":"Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36374959","citation_count":7,"is_preprint":false},{"pmid":"31313037","id":"PMC_31313037","title":"Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.","date":"2019","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31313037","citation_count":7,"is_preprint":false},{"pmid":"11153911","id":"PMC_11153911","title":"Chromosomal localization, genomic characterization, and mapping to the Noonan syndrome critical region of the human Deltex (DTX1) gene.","date":"2000","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11153911","citation_count":7,"is_preprint":false},{"pmid":"38029800","id":"PMC_38029800","title":"Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway.","date":"2023","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/38029800","citation_count":6,"is_preprint":false},{"pmid":"39587541","id":"PMC_39587541","title":"Extrachromosomal circular DNA containing DTX1 promotes cell growth in hydroquinone-induced malignantly transformed cells by regulating the transcription of DTX1.","date":"2024","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39587541","citation_count":4,"is_preprint":false},{"pmid":"40660011","id":"PMC_40660011","title":"DTX1 Modulates Microglial M1 Polarization and Exacerbates Neuroinflammation in Traumatic Brain Injury Model Rats through NF-κB/IRF5.","date":"2025","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/40660011","citation_count":4,"is_preprint":false},{"pmid":"39319341","id":"PMC_39319341","title":"Overexpression of DTX1 inhibits D-GalN/TNF-α-induced pyroptosis and inflammation in hepatocytes by regulating NLRP3 ubiquitination.","date":"2024","source":"Toxicology research","url":"https://pubmed.ncbi.nlm.nih.gov/39319341","citation_count":1,"is_preprint":false},{"pmid":"41577987","id":"PMC_41577987","title":"DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41577987","citation_count":0,"is_preprint":false},{"pmid":"42090073","id":"PMC_42090073","title":"DTX1 Regulates Aortic Dissection Progression by Modulating Vascular Smooth Muscle Cell Phenotypic Switching via Ubiquitination of ITGA5.","date":"2026","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/42090073","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10027,"output_tokens":1621,"usd":0.027198,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8395,"output_tokens":2601,"usd":0.0535,"stage2_stop_reason":"end_turn"},"total_usd":0.080698,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"DTX1 colocalizes with Notch1 on tubulovesicular recycling endosomes and controls Notch1 endosomal sorting; DTX1 silencing leads to enhanced Notch1 recycling via a rab4a-mediated route, increasing Notch1 cell-surface levels and signaling. DTX1 also ubiquitinates PI5P4Kγ (a lipid kinase for PI(4,5)P2 production) on recycling endosomes, and loss of PI5P4Kγ activity decreases Notch1 recycling, supporting a model where DTX1 controls Notch1 transport by targeting PI5P4Kγ.\",\n      \"method\": \"siRNA silencing, immunolocalization, activity-based ubiquitination substrate screen, Rab4a transport assays, pharmacological inactivation of PI5P4Kγ\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (localization, loss-of-function, substrate screen, epistasis with rab4a and PI5P4Kγ) in a single focused mechanistic study\",\n      \"pmids\": [\"29440432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX1 interacts with NLRP3 and promotes its ubiquitination and proteasomal degradation, thereby suppressing hepatocyte pyroptosis and inflammation. HNF4α transcriptionally activates DTX1 by binding its promoter.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, luciferase reporter assay, chromatin immunoprecipitation, Western blotting, flow cytometry\",\n      \"journal\": \"Toxicology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and ubiquitination assay with ChIP for transcriptional regulation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"39319341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX1 directly interacts with TUBB3 and promotes its ubiquitination and degradation in Kupffer cells, thereby blocking AKT signaling and suppressing M2 polarization of tumor-associated macrophages in hepatocellular carcinoma.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function experiments, in vivo xenograft/HCC models\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay and in vivo validation, single lab\",\n      \"pmids\": [\"41577987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX1 directly interacts with ITGA5 and promotes its ubiquitination at lysine 137, leading to proteasome-dependent degradation; DTX1 overexpression maintains the contractile phenotype of vascular smooth muscle cells and attenuates aortic dissection progression in vivo.\",\n      \"method\": \"Co-immunoprecipitation, protein stability analysis, gain/loss-of-function in HASMCs and HEK-293T cells, BAPN-induced AD mouse model, Western blotting, immunofluorescence\",\n      \"journal\": \"Cardiovascular drugs and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination site mapping (K137), in vivo model, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"42090073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX1 promotes microglial M1 polarization and neuroinflammation following traumatic brain injury; DTX1 overexpression increases proinflammatory cytokines and iNOS (M1 markers) and reduces Arg1 (M2 marker) via the NF-κB/IRF5 pathway, while DTX1 knockdown shifts microglia toward the M2 anti-inflammatory phenotype.\",\n      \"method\": \"Adenoviral overexpression and siRNA knockdown in vitro and in vivo (rat TBI model), gain/loss-of-function, cytokine measurement, marker expression analysis\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both gain- and loss-of-function with in vivo validation, single lab, pathway placement via NF-κB/IRF5\",\n      \"pmids\": [\"40660011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The human DTX1 gene encodes a cytoplasmic protein that functions as a positive regulator of the Notch signaling pathway; the gene maps to chromosomal region 12q24 and is composed of nine exons.\",\n      \"method\": \"Genomic characterization, chromosomal mapping, cDNA analysis\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genomic/positional characterization only, functional annotation inferred from prior literature without direct mechanistic experiment described in this paper\",\n      \"pmids\": [\"11153911\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DTX1 is an E3 ubiquitin ligase that controls Notch1 endosomal sorting by ubiquitinating PI5P4Kγ on recycling endosomes to regulate PI(4,5)P2 production and receptor recycling, and additionally ubiquitinates substrates including NLRP3 (promoting its degradation to suppress inflammasome-driven pyroptosis), TUBB3 (inhibiting AKT-mediated M2 macrophage polarization), and ITGA5 (maintaining vascular smooth muscle cell contractile phenotype), while also modulating microglial M1 polarization through NF-κB/IRF5 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DTX1 is a cytoplasmic E3 ubiquitin ligase that regulates Notch signaling and shapes cellular phenotype by directing substrate ubiquitination and degradation [#0, #5]. On tubulovesicular recycling endosomes, DTX1 colocalizes with Notch1 and controls its endosomal sorting by ubiquitinating the lipid kinase PI5P4K\\u03b3; loss of DTX1 enhances Rab4a-mediated Notch1 recycling and raises cell-surface Notch1 and signaling, while loss of PI5P4K\\u03b3 activity reduces Notch1 recycling, placing DTX1 upstream of receptor transport via control of PI(4,5)P2 production [#0]. Beyond Notch trafficking, DTX1 acts on a series of substrates whose degradation reprograms inflammatory and structural cell states: it ubiquitinates NLRP3 to promote its proteasomal degradation and suppress hepatocyte pyroptosis, with DTX1 itself transcriptionally activated by HNF4\\u03b1 [#1]; it degrades TUBB3 in Kupffer cells to block AKT signaling and suppress M2 polarization of tumor-associated macrophages [#2]; and it ubiquitinates ITGA5 at lysine 137 to maintain the contractile phenotype of vascular smooth muscle cells and attenuate aortic dissection [#3]. DTX1 also drives microglial M1 polarization and neuroinflammation through NF-\\u03baB/IRF5 signaling following traumatic brain injury [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established the molecular identity of human DTX1 as a cytoplasmic protein positioned as a positive regulator of Notch signaling, providing the gene model on which later mechanistic work was built.\",\n      \"evidence\": \"genomic characterization, chromosomal mapping (12q24), and cDNA analysis\",\n      \"pmids\": [\"11153911\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Functional annotation inferred from prior literature without direct mechanistic experiment in this study\",\n        \"No biochemical demonstration of E3 ligase activity\",\n        \"No substrate identified\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved how DTX1 controls Notch1 signaling at the level of receptor trafficking, showing it restrains Notch1 recycling by ubiquitinating a lipid kinase on recycling endosomes rather than acting solely on the receptor.\",\n      \"evidence\": \"siRNA silencing, immunolocalization, ubiquitination substrate screen, Rab4a transport assays, and pharmacological inactivation of PI5P4K\\u03b3\",\n      \"pmids\": [\"29440432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DTX1 directly ubiquitinates Notch1 in addition to PI5P4K\\u03b3 not resolved here\",\n        \"Ubiquitination site(s) on PI5P4K\\u03b3 not mapped\",\n        \"Regulation of DTX1 recruitment to recycling endosomes unknown\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended DTX1 substrate repertoire to NLRP3, defining a degradative anti-inflammatory axis and placing DTX1 expression under HNF4\\u03b1 transcriptional control.\",\n      \"evidence\": \"reciprocal Co-IP, ubiquitination assay, luciferase reporter, and ChIP in a hepatocyte pyroptosis context\",\n      \"pmids\": [\"39319341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Ubiquitin chain type and degradation route not characterized\",\n        \"Single-lab study without independent replication\",\n        \"Direct vs indirect ubiquitination of NLRP3 not fully dissected\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated DTX1 in driving proinflammatory microglial M1 polarization via NF-\\u03baB/IRF5 signaling after traumatic brain injury, linking it to neuroinflammatory phenotype switching.\",\n      \"evidence\": \"adenoviral overexpression and siRNA knockdown with cytokine/marker analysis in vitro and in a rat TBI model\",\n      \"pmids\": [\"40660011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Ubiquitination substrate underlying the NF-\\u03baB/IRF5 effect not identified\",\n        \"Direction opposite to the anti-inflammatory NLRP3 axis not mechanistically reconciled\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Defined two further degradative substrate relationships\\u2014TUBB3 in Kupffer cells (suppressing AKT-driven macrophage M2 polarization) and ITGA5 at K137 in vascular smooth muscle cells (maintaining contractile phenotype)\\u2014broadening DTX1's role in tissue-specific phenotype control.\",\n      \"evidence\": \"Co-IP, ubiquitination assays with site mapping, gain/loss-of-function, and in vivo HCC and BAPN-induced aortic dissection models\",\n      \"pmids\": [\"41577987\", \"42090073\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Ubiquitin chain linkage types not defined for TUBB3\",\n        \"Whether substrate selectivity is governed by tissue-specific cofactors unknown\",\n        \"Single-lab studies for each substrate\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DTX1 selects among its diverse substrates (PI5P4K\\u03b3, NLRP3, TUBB3, ITGA5) across cell types, and how its opposing pro- and anti-inflammatory outputs are reconciled, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No unifying model for substrate recognition or adaptor requirement\",\n        \"Structural basis of substrate engagement uncharacterized\",\n        \"Cell-type determinants of opposing inflammatory effects unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NOTCH1\", \"PIP4K2C\", \"NLRP3\", \"TUBB3\", \"ITGA5\", \"HNF4A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}